贵州医科大学学报2024,Vol.49Issue(3) :313-328.DOI:10.19367/j.cnki.2096-8388.2024.03.001

汉防己乙素衍生物LYY-47对三阴性乳腺癌细胞及其多倍体巨瘤细胞增殖、凋亡的作用和机制

Effect and mechanism of tetrandrine derivative LYY-47 on proliferation and apoptosis of triple negative breast cancer cells and their polyploid giant cancer cells

余晓静 张望明 贺天辉 刘小花 艾海锋 安丽君 杨留启 潘卫东 刘杰麟
贵州医科大学学报2024,Vol.49Issue(3) :313-328.DOI:10.19367/j.cnki.2096-8388.2024.03.001

汉防己乙素衍生物LYY-47对三阴性乳腺癌细胞及其多倍体巨瘤细胞增殖、凋亡的作用和机制

Effect and mechanism of tetrandrine derivative LYY-47 on proliferation and apoptosis of triple negative breast cancer cells and their polyploid giant cancer cells

余晓静 1张望明 2贺天辉 3刘小花 2艾海锋 2安丽君 2杨留启 2潘卫东 4刘杰麟5
扫码查看

作者信息

  • 1. 贵州医科大学基础医学院免疫学教研室,贵州贵阳 550025;九江学院附属医院检验科,江西九江 332000
  • 2. 贵州医科大学基础医学院免疫学教研室,贵州贵阳 550025
  • 3. 德江县民族中医院检验科,贵州铜仁 565200
  • 4. 贵州大学药学院,贵州贵阳 550025
  • 5. 贵州医科大学基础医学院免疫学教研室,贵州贵阳 550025;贵州医科大学省部共建药用植物功效与利用国家重点实验室,贵州贵阳 550014
  • 折叠

摘要

目的 探讨汉防己乙素衍生物LYY-47对三阴性乳腺癌(TNBC)细胞及其多倍体巨瘤细胞(PGCCs)增殖、凋亡的作用和机制.方法 取TNBC MDA-MB-231细胞和MDA-MB-436细胞培养至对数生长期,诱导形成PGCCs,培养35 d,采用苏木素-伊红(H&E)染色观察不同培养时间时2种细胞的PGCCs形态学特征并进行计数;收集MDA-MB-231细胞、PGCCs及其子代细胞,采用流式细胞仪检测分析细胞周期,采用Western blot检测周期相关蛋白[细胞周期蛋白依赖性激酶1(CDK1)和细胞周期蛋白B1(CyclinB1)]、干性相关蛋白[乙醛脱氢酶1 A1(ALDH1A1)、白细胞分化抗原44(CD44)及白细胞分化抗原133(CD133)]、DNA损伤修复相关蛋白[布卢姆(BLM)、Rad51及乳腺癌易感基因1(BRCA1)]及凋亡相关蛋白[BCL2-相关X蛋白(Bax)、B淋巴细胞瘤蛋白-2(Bcl-2)、裂解凋亡蛋白酶-3(cleaved Caspase-3)及裂解凋亡蛋白酶-8(cleaved Caspase-8)]的表达,采用噻唑蓝(MTT)法和克隆形成实验检测细胞活力和细胞集落数,采用细胞免疫荧光实验检测磷酸化组蛋白2AX(γ-H2AX)的表达;采用荧光偏振实验检测BLM DNA解旋酶的活性;收集对数生长期MDA-MB-231细胞,分为对照组(同等体积的完全培养基)、紫杉醇(PTX)组(500 nmol/L PTX)、3-CF3,4-F-苯基类似物(ML216)组(3 μmol/L ML216)及ML216+PTX组(500 nmol/L PTX和3 µmol/L ML216),采用Image J软件计数各组细胞数;收集对数生长期MDA-MB-231细胞及其PGCCs子代细胞,分为对照组(0.00 µmol/L)、LYY-47给药组(2.50 μmol/L、5.00 μmol/L及6.50 µmol/L),采用流式细胞仪检测上述各组细胞的凋亡情况;6周龄雌性无特定病原体(SPF)级无胸腺BALB/c裸鼠12只,皮下分别注射5 × 106个MDA-MB-231细胞及其PGCCs子代细胞,每隔3天测量1次肿瘤体积,连续29 d,处死裸鼠剥离肿瘤、称重,取肿瘤组织制作切片,采用H&E染色和免疫组织化学染色观察细胞形态和检测BLM、Ki-67的表达.结果 与TNBC MDA-MB-231和MDA-MB-436细胞相比,PTX诱导的PGCCs出现增大的细胞核和细胞质区域,通过不对称分裂产生子代细胞;与MDA-MB-231细胞相比,PGCCs中S期和G2/M期细胞增加、CDK1和CyclinB1蛋白表达下调(P<0.05或P<0.01),其子代细胞中S期细胞增加、G2/M期细胞减少且CDK1、CyclinB1蛋白表达上调(P<0.05或P<0.01),PGCCs及其子代细胞中ALDH1A1、CD44及CD133蛋白表达上调(P<0.05),PGCCs子代细胞的增殖和克隆形成能力增强(P<0.05),γ-H2AX、BLM、BRCA1及Rad51蛋白表达上调(P<0.05);与PTX组相比,ML216+PTX组PGCCs形成的数量明显减少(P<0.01);PGCCs子代细胞体内成瘤的生长速度、肿瘤的体积和重量均大于MDA-MB-231细胞(P<0.01),瘤体中BLM与Ki-67均呈高表达(P<0.01);与对照组相比,LYY-47给药组BLM642-1290DNA解旋酶的ATPase、ds-DNA解链活性以及DNA结合活性均下调(P<0.05),MDA-MB-231细胞及其PGCCs子代细胞中 BLM、Rad51及BRCA1蛋白表达也均下调(P<0.05);与对照组相比,LYY-47给药组和ML216给药组MDA-MB-231及其PGCCs子代细胞增殖和克隆形成能力降低(P<0.05),LYY-47给药组能够引起MDA-MB-231及其PGCCs子代细胞G2/M期细胞增加(P<0.05)、S期细胞减少(P<0.05)、细胞内周期相关蛋白CDK1与CyclinB1的表达下调(P<0.05),ML216给药组MDA-MB-231及其PGCCs子代细胞G1期细胞增多、S期细胞减少(P<0.05);与对照组比较,LYY-47给药组MDA-MB-231细胞及其PGCCs子代细胞的总凋亡比例增加、Bcl-2表达下调及Bax、cleaved Caspase-3、cleaved Caspase-8 蛋白表达上调(P<0.05).结论 LYY-47 和 ML216 可影响 TNBC 及其PGCCs子代细胞的增殖,其机制可能与抑制BLM DNA解旋酶诱导细胞凋亡和阻滞细胞周期有关.

Abstract

Objective To explore the effects and mechanism of tetrandrine derivative LYY-47 on the proliferation and apoptosis of triple negative breast cancer(TNBC)cells and polyploid giant cancer cells(PGCCs)with budding.Methods TNBC MDA-MB-231 cells and MDA-MB-436 cells were cultured to logarithmic growth phase to induce PGCCs.After 35 days of culture,H&E staining was used to observe the morphological characteristics of PGCCs of the two types at different culture time,and the PGCCs were counted.MDA-MB-231 cells,PGCCs and their PGCCs with budding were collected and analyzed for cell cycle by Flow cytometry.Western blot was used to detect the expression of cyclin-related proteins[cyclin dependent kinase 1(CDK1)and Cell cycle proteinB1(CyclinB1)],stemness related protein[acetaldehyde dehydrogenase1A1(ALDH1A1),cluster of differentiation 44(CD44)and cluster of differentiation 133(CD133)],DNA damage repair related protein[Bloom(BLM),(Rad51)and breast cancer susceptibility gene 1(BRCA1)]and apoptosis-related proteins[Bcl-2-associated X protein(Bax),B-cell lymphoma protein2(Bcl-2),cleaved Caspase-3,and cleaved Caspase-8].Methyl thiazol tetrazolium(MTT)assay and colony formation assay were used to detect cell viability and colony number.Immunofluorescence assay was used to detect the expression of phosphorylated histone 2AX(γ-H2AX).The activity of BLM DNA helicase was detected by fluorescence polarization assay.MDA-MB-231 cells in logarithmic growth phase were collected.They were divided into the control group(the same volume of complete medium),PTX group(500 nmol/L PTX),3-CF3,4-F-phenyl analog(ML216)group(3 µmol/L ML216)and ML216+PTX group(500 nmol/L PTX and 3 µmol/L ML216).Image J software was used to count the number of cells in each group.Logarithmic growth MDA-MB-231 cells and PGCCs with budding were collected and divided into the control group(0.00 μmol/L)and LYY-47 treatment group(2.50 µmol/L,5.00 µmol/L,and 6.50 µmol/L).The apoptosis of the above cells was detected by flow cytometry.Twelve 6-week-old female nude mice of specific pathogen free(SPF)athymic BALB/c were subcutaneously injected with 5 × 106 MDA-MB-231 cells and their PGCCs with budding,respectively.The tumor volume was measured every 4 days for 29 consecutive days.The tumor tissues were taken for H&E staining and immunohistochemical staining to observe cell morphology and detect the expression of BLM and Ki-67.Results PGCCs induced by PTX showed enlarged nuclear and cytoplasmic areas compared with TNBC MDA-MB-231 cells and MDA-MB-436 cells,which produced progeny cells through asymmetric division.Compared with MDA-MB-231 cells,the number of S and G2/M phase cells increased in PGCCs,and the expression of CDK1 and CyclinB1 was significantly down-regulated(P<0.05 or P<0.01),and the number of S phase cells in PGCCs with budding increased,but G2/M phase cells decreased,while the expression of CDK1 and CyclinB1 was up-regulated(P<0.05 or P<0.01).The expressions of stemness-related proteins ALDH1A1,CD44 and CD133 were significantly up-regulated in PGCCs with budding(P<0.05)and the proliferation and colony formation ability of PGCCs with budding were significantly enhanced(P<0.05);The protein expression of γ-H2AX,BLM,BRCA1 and Rad51 was up-regulated(P<0.05).Compared with the PTX group,the number of PGCCs formed in the ML216+PTX group was significantly reduced(P<0.01).The tumor growth rate,tumor volume and weight of PGCCs with budding were significantly higher than those of the MDA-MB-231 cells(P<0.01),and BLM,Ki-67 were highly expressed in the tumor(P<0.01).Compared with the control group,The ATPase activity of DNA helicase,dsDNA unfolding activity and DNA binding activity of BLM642-1290 were down-regulated in LYY-47 treatment group,and the expression of BLM,Rad51 and BRCA1 proteins in MDA-MB-231 cells and PGCCs with budding was also down-regulated(P<0.05).Compared with the control group,treatment with LYY-47 and ML216 significantly decreased the proliferation and colony formation ability of MDA-MB-231 cells and PGCCs with budding(P<0.05).Treatment with LYY-47 significantly increased the number of cells in G2/M phase(P<0.05)and decreased the number of cells in S phase(P<0.05).The expression of cycle-related proteins CDK1 and CyclinB1 in the cells was down-regulated(P<0.05)in MDA-MB-231 and PGCCs with budding.ML216 treatment significantly increased the number of cells in G1 phase(P<0.05)and decreased the number of cells in S phase(P<0.05)in MDA-MB-231 and PGCCs with budding.Compared with the control group,LYY-47 treatment significantly increased the proportion of total apoptosis and up-regulated the expression of apoptosis-related proteins Bax,cleaved Caspase-3 and cleaved Caspase-8 in MDA-MB-231 cells and PGCCs with budding(P<0.05).The expression of Bcl-2 was down-regulated(P<0.05).Conclusions LYY-47 and ML216 can affect the proliferation of triple-negative breast cancer cells and PGCCs with budding,which may be related to the inhibition of BLM DNA helicase induced apoptosis and cell cycle arrest.

关键词

乳腺肿瘤/DNA解旋酶类/细胞增殖/细胞凋亡/汉防己乙素衍生物/多倍体巨瘤细胞/BLM/DNA解旋酶

Key words

breast neoplasms/DNA helicases/cell proliferation/apoptosis/tetrandrine derivatives/polyploid giant cancer cells/BLM DNA helicase

引用本文复制引用

基金项目

国家自然科学基金(82260458)

贵州省科技支撑项目(黔科合支撑[2020]4Y120)

贵州医科大学省部共建药用植物功效与利用国家重点实验室开放课题项目(FAMP202110K)

国基培育项目(21NSFCP27)

出版年

2024
贵州医科大学学报
贵阳医学院

贵州医科大学学报

CSTPCD
影响因子:0.827
ISSN:2096-8388
参考文献量26
段落导航相关论文